SG Americas Securities LLC purchased a new stake in shares of STAAR Surgical (NASDAQ:STAA) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 77,891 shares of the medical instruments supplier’s stock, valued at approximately $2,486,000.
A number of other institutional investors also recently modified their holdings of STAA. Vanguard Group Inc boosted its holdings in shares of STAAR Surgical by 60.9% in the 3rd quarter. Vanguard Group Inc now owns 2,754,944 shares of the medical instruments supplier’s stock valued at $132,238,000 after acquiring an additional 1,042,724 shares during the last quarter. Vanguard Group Inc. boosted its holdings in STAAR Surgical by 60.9% during the third quarter. Vanguard Group Inc. now owns 2,754,944 shares of the medical instruments supplier’s stock worth $132,238,000 after buying an additional 1,042,724 shares in the last quarter. Baillie Gifford & Co. boosted its holdings in STAAR Surgical by 33.8% during the third quarter. Baillie Gifford & Co. now owns 1,550,179 shares of the medical instruments supplier’s stock worth $74,409,000 after buying an additional 391,629 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in STAAR Surgical by 46.4% during the third quarter. Renaissance Technologies LLC now owns 906,000 shares of the medical instruments supplier’s stock worth $43,488,000 after buying an additional 287,000 shares in the last quarter. Finally, Kornitzer Capital Management Inc. KS purchased a new stake in STAAR Surgical during the third quarter worth $12,893,000. Institutional investors and hedge funds own 85.79% of the company’s stock.
NASDAQ:STAA opened at $34.08 on Monday. The company has a quick ratio of 4.76, a current ratio of 5.35 and a debt-to-equity ratio of 0.01. The firm has a market cap of $1.50 billion, a price-to-earnings ratio of 3,408.00 and a beta of 1.99. STAAR Surgical has a fifty-two week low of $13.60 and a fifty-two week high of $54.00.
STAAR Surgical Profile
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.
Recommended Story: Earnings Reports
Want to see what other hedge funds are holding STAA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STAAR Surgical (NASDAQ:STAA).
Receive News & Ratings for STAAR Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical and related companies with MarketBeat.com's FREE daily email newsletter.